At the @-month follow-up , the ejection fraction was significantly increased in the BMC-treated group compared to controls ( @ @ vs. @ @ ; p < @ ) , whereas the WMSI were significantly decreased ( @ @ vs. @ @ ; p < @ ) , with no occurrences of life-threatening arrhythmias or death .